回复@TearsinFears: 分析师在earning call中一直在问这个guidance的问题，为什么这么保守，我从管理层的角度明白他们为什么这么做，但是和很多分析师的预测是有落差的。//@TearsinFears:回复@Rax郝毅:对比一下 2019的outlook， 其实说不上非常弱， 
2019 Financial Guidance
Guardant Health now expects full year 2019 total revenue to be in the range of $145 million to $150 million, representing 60% to 65% growth over full year 2018. This compares to the company's previous full year 2019 total revenue guidance of $130 to $135 million.
2020 Financial Guidance
Guardant Health expects full year 2020 revenue to be in the range of $275.0 million to $285.0 million, representing 31% growth over the full year 2019 at the midpoint of the range. Net loss is expected to be in the range of $155.0 million to $160.0 million in 2020.